Pliant Therapeutics (PLRX)
NASDAQ:PLRX
Holding PLRX?
Track your performance easily

Pliant Therapeutics (PLRX) Financial Statements

389 Followers

Pliant Therapeutics Financial Overview

Pliant Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.086; its P/E ratio is -4.31; Pliant Therapeutics is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.96. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue---$ 248.00K$ 1.33M
Gross Profit---$ 248.00K$ 1.33M
EBIT$ -55.85M$ -40.79M$ -47.69M$ -47.33M$ -41.47M
EBITDA$ -55.20M$ -40.32M-$ -50.23M$ -42.94M
Net Income Common Stockholders$ -60.64M$ -41.11M$ -41.49M$ -41.19M$ -36.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 436.61M$ 494.25M$ 523.61M$ 555.16M$ 577.31M
Total Assets$ 483.73M$ 512.15M$ 540.46M$ 574.89M$ 593.68M
Total Debt$ 60.23M$ 11.37M$ 12.08M$ 14.54M$ 15.19M
Net Debt$ -376.38M$ -482.87M$ -511.53M$ -540.62M$ -562.13M
Total Liabilities$ 91.05M$ 38.58M$ 37.42M$ 41.83M$ 35.96M
Stockholders Equity$ 392.68M$ 473.58M$ 503.05M$ 533.07M$ 561.92M
Cash Flow-
Free Cash Flow$ -46.55M$ -25.16M-$ -25.44M$ -30.39M
Operating Cash Flow$ -45.30M$ -25.10M$ -36.22M$ -24.84M$ -30.23M
Investing Cash Flow$ 10.70M$ 31.92M$ 38.25M$ -22.98M$ -174.21M
Financing Cash Flow$ 684.00K$ 219.00K$ 699.00K$ 161.00K$ 273.33M
Currency in USD

Pliant Therapeutics Earnings and Revenue History

Pliant Therapeutics Debt to Assets

Pliant Therapeutics Cash Flow

Pliant Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis